Prepare for your visit

Stephanie Cochran

Nurse Practitioner · Germantown, TN · NPI 1770877821

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$5,927.91

in general payments reported to CMS, 2019-2025 · $1,726 in 2025

The $1,726 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).

Who reported paying

General payments only, top 6 by amount.

Novo Nordisk INC $1,066.86
Abbvie INC. $966.19
Astrazeneca Pharmaceuticals LP $929.96
Pfizer INC. $721.56
Lilly USA, LLC $352.39
Glaxosmithkline, LLC. $300.94

Drugs and devices associated with these payments

Ozempic Nurtec Odt Ubrelvy Rybelsus Airsupra Zavzpret Mounjaro Breztri Wegovy Kerendia Zepbound Qulipta

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Stephanie Cochran listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10725596/stephanie-cochran